Branch; Clive Leslie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Branch; Clive Leslie.The latest application filed is for "glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders".

Company Profile

0.15.26

Branch; Clive Leslie - Essex GB
Branch; Clive Leslie - Harlow GB
Branch; Clive Leslie - Bishops Stortford GB
Branch, Clive Leslie - King of Prussia PA
Branch; Clive Leslie - Dorking GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glyt1 Transporter Inhibitors And Uses Thereof In Treatment Of Neurological And Neuropsychiatric Disorders App 20120004273 - Ahmad; Nadia Mamoona ; et al.	2012-01-05
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,928,125 - Branch , et al. April 19, 2	2011-04-19
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,928,124 - Branch , et al. April 19, 2	2011-04-19
N-aroyl cyclic amines Grant 7,919,507 - Branch , et al. April 5, 2	2011-04-05
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,897,618 - Branch , et al. March 1, 2	2011-03-01
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,893,090 - Branch , et al. February 22, 2	2011-02-22
N-aroyl cyclic amines Grant 7,741,329 - Branch , et al. June 22, 2	2010-06-22
Oxygen Containing Heterocycles As Glycine Transporter Inhibiting Compounds App 20100137428 - Bozzoli; Andrea ; et al.	2010-06-03
1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one Derivatives And Their Use As Glycine Transporter Inhibitors App 20100029700 - Branch; Clive Leslie ; et al.	2010-02-04
2-amino-1-phenylethylcarboxamide Derivatives App 20090286828 - Bozzoli; Andrea ; et al.	2009-11-19
Glycine Transport Inhibitors App 20090270510 - Bradley; Daniel Marcus ; et al.	2009-10-29
N-'4-4(4-morpholinyl) Phenyl!- '(4-piperidinyl) Methyl! Carboxamide Derivatives And Their Use As Glycine Transporter Inhibitors App 20090253700 - Branch; Clive Leslie ; et al.	2009-10-08
Compounds Having Activity At The Glycine Transporter Glyt1 And Uses Thereof App 20090227629 - Branch; Clive Leslie ; et al.	2009-09-10
Compounds Having Morpholinyl And Piperidinyl Groups For Use As Glyt1 Inhibitors App 20090221577 - Branch; Clive Leslie ; et al.	2009-09-03
N-aroyl Cyclic Amines App 20090093478 - BRANCH; Clive Leslie ; et al.	2009-04-09
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20090036442 - BRANCH; Clive Leslie ; et al.	2009-02-05
N-aroyl Cyclic Amines App 20090029986 - BRANCH; Clive Leslie ; et al.	2009-01-29
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20090012083 - BRANCH; Clive Leslie ; et al.	2009-01-08
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20090012122 - BRANCH; Clive Leslie ; et al.	2009-01-08
N-aroyl Cyclic Amines App 20090012073 - BRANCH; Clive Leslie ; et al.	2009-01-08
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,470,710 - Branch , et al. December 30, 2	2008-12-30
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20080318944 - BRANCH; Clive Leslie ; et al.	2008-12-25
Glycine Transport Inhibitors App 20080287547 - Bradley; Daniel Marcus ; et al.	2008-11-20
Acylated Piperidines as Glycine Transporter Inhibitors App 20080255144 - Bradley; Daniel Marcus ; et al.	2008-10-16
N-aroyl cyclic amines Grant 7,432,270 - Branch , et al. October 7, 2	2008-10-07
N-aroyl piperazine derivatives as orexin receptor antagonists Grant 7,405,217 - Branch , et al. July 29, 2	2008-07-29
Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor Grant 7,365,077 - Branch , et al. April 29, 2	2008-04-29
Piperazine Derivatives As Glyt 1 Inhibitors App 20080090822 - Bradley; Daniel Marcus ; et al.	2008-04-17
N-aroyl Piperazine Derivatives As Orexin Receptor Antagonists App 20070167457 - BRANCH; Clive Leslie ; et al.	2007-07-19
N-aroyl piperazine derivatives as orexin receptor antagonists Grant 7,166,608 - Branch , et al. January 23, 2	2007-01-23
Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor App 20060252769 - Branch; Clive Leslie ; et al.	2006-11-09
Morpholine derivatives as antagonists of orexin receptors Grant 6,943,160 - Branch , et al. September 13, 2	2005-09-13
Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors Grant 6,855,717 - Branch , et al. February 15, 2	2005-02-15
N-aroyl piperazine derivatives as orexin receptor antagonists App 20040242575 - Branch, Clive Leslie ; et al.	2004-12-02
N-aroyl cyclic amine derivatives as orexin receptor antagonists App 20040180887 - Branch, Clive Leslie ; et al.	2004-09-16
N-aroyl cyclic amines App 20040143115 - Branch, Clive Leslie ; et al.	2004-07-22
Morpholine derivatives as antagonists of orexin receptors App 20040058921 - Branch, Clive Leslie ; et al.	2004-03-25
Piperdines for use as orexin receptor antagonists Grant 6,677,354 - Branch , et al. January 13, 2	2004-01-13
Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors App 20030191314 - Branch, Clive Leslie ; et al.	2003-10-09
Piperdines for use as orexin receptor antagonists App 20030186964 - Branch, Clive Leslie ; et al.	2003-10-02
Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors Grant 6,465,485 - Branch , et al. October 15, 2	2002-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.